- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT02114879
Enhanced Medical Rehabilitation in Older Adults (EMR)
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
The intervention involves physical and occupational therapy for patients who have been admitted to a skilled nursing facility for therapy following a disabling medical event.
Participants in this study will be randomly assigned to receive either Enhanced or standard of care therapy, meaning they will either receive their PT (Physical Therapy)& OT(Occupational Therapy) from therapists who have been specially trained in the study intervention or from therapists with normal training. Participants will be assessed at baseline, 30, 60, and 90 days after baseline, and at the date of their discharge from the skilled nursing facility.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Missouri
-
Saint Louis, Missouri, Estados Unidos, 63110
- Washington University School of Medicine
-
Saint Louis, Missouri, Estados Unidos, 63105
- Barnes-Jewish Extended Care
-
Saint Louis, Missouri, Estados Unidos, 63125
- Alexian Brothers Sherbrooke Village
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- 65 and older
- Admitted to a skilled nursing facility for post-acute care from PT and OT for 2 weeks or more.
Exclusion Criteria:
- Language, visual or hearing barriers to participation
- Medical illness preventing study participation or accurate data collection
- Moderate-severe dementia (demonstrated by chart diagnosis and/or short blessed score greater than 13)
- Progressive neurological condition such that recovery of function is not feasible
- Patient did not have the ability to walk prior to hospitalization (e.g. paraplegic)
- Schizophrenia or other chronic or current psychotic disorder.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Standard of Care Rehabilitation
|
Daily PT/OT provided by therapists not trained in the treatment intervention.
|
|
Experimental: Enhanced Medical Rehabilitation
|
Daily PT/OT provided by therapists trained in Enhanced Medical Rehabilitation.
This training focuses on improved communication, patient engagement, and intensity.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Barthel Index Score
Periodo de tiempo: Baseline and Discharge, an average of 24 days.
|
Barthel Index scores range from 0 to 100, with higher scores indicating greater levels of function.
|
Baseline and Discharge, an average of 24 days.
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Gait Speed (Determined by 4 or 10 Meter Walk Test)
Periodo de tiempo: Discharge, an average of 24 days after baseline.
|
Meters walked per second.
|
Discharge, an average of 24 days after baseline.
|
|
Distance Ambulated in 6-Minute Walk Test
Periodo de tiempo: Discharge, an average of 24 days after baseline.
|
Feet walked during 6 minute interval.
|
Discharge, an average of 24 days after baseline.
|
|
Self-reported Barthel Index
Periodo de tiempo: 30, 60, and 90 Days Post Admission to the SNF
|
Barthel Index scores range from 0 to 100, with higher scores indicating greater levels of function.
Conducted as a self-report at timepoints where patient was not in an institutional setting.
|
30, 60, and 90 Days Post Admission to the SNF
|
|
Discharge Disposition
Periodo de tiempo: Discharge, an average of 24 days after baseline.
|
Number of participants discharged from skilled nursing facility to home
|
Discharge, an average of 24 days after baseline.
|
|
Rehospitalizations
Periodo de tiempo: Days 30, 60, and 90 post admission to a SNF as well as at Discharge
|
Assesses whether the participant was readmitted to the hospital.
|
Days 30, 60, and 90 post admission to a SNF as well as at Discharge
|
Colaboradores e Investigadores
Publicaciones y enlaces útiles
Publicaciones Generales
- Bland MD, Birkenmeier RL, Barco P, Lenard E, Lang CE, Lenze EJ. Enhanced Medical Rehabilitation: Effectiveness of a clinical training model. NeuroRehabilitation. 2016 Oct 14;39(4):481-498. doi: 10.3233/NRE-161380.
- Ercal B, Rodebaugh TL, Bland MD, Barco P, Lenard E, Lang CE, Miller JP, Yingling M, Lenze EJ. Executive Function Moderates Functional Outcomes of Engagement Strategies During Rehabilitation in Older Adults. Am J Phys Med Rehabil. 2021 Jul 1;100(7):635-642. doi: 10.1097/PHM.0000000000001739.
- Lenze EJ, Lenard E, Bland M, Barco P, Miller JP, Yingling M, Lang CE, Morrow-Howell N, Baum CM, Binder EF, Rodebaugh TL. Effect of Enhanced Medical Rehabilitation on Functional Recovery in Older Adults Receiving Skilled Nursing Care After Acute Rehabilitation: A Randomized Clinical Trial. JAMA Netw Open. 2019 Jul 3;2(7):e198199. doi: 10.1001/jamanetworkopen.2019.8199.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- R01 MH099011A1
- 5R01MH099011-02 (Subvención/contrato del NIH de EE. UU.)
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .